Chinese Biotech, Investments Are on Track to Face New US Curbs

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from government-funded contracts and authorize the Trump administration to bar US investment in Chinese AI and advanced computing.